3B Blackbio Diagnostics Ltd. logo

3B Blackbio Diagnostics Ltd. (3BBLACKBIO)

Market Closed
11 Aug, 22:00
MSE MSE
1,206. 45
-37.55
-3.0185%
9.91B Market Cap
- P/E Ratio
- Div Yield
991 Volume
- Eps
1,244
Previous Close
Add Transaction
Day Range
1,194.65 1,248.05
Year Range
1,083.5 1,750
Want to track 3BBLACKBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

3B Blackbio Diagnostics Ltd. (3BBLACKBIO) Statistics

Valuation metrics

Market Cap 9.91B
Enterprise value 98.49M
Trailing P/E (ttm) 16.71
Forward P/E -
PEG ratio 1.24
Price/Sales (ttm) 6.88
Price/Book (mrq) 3.04
Enterprise Value/Revenue 6.22
Enterprise Value/EBITDA 15.45

Overview

Shares outstanding 8.58M
Float 2.69M
Shares short -
% Held by insiders 0.66%
% Held by institutions 0.02%
Average volume (10 days) 1.25K
Average volume (90 days) 4.26K

Price summary

52-Week low 1,083.5
52-Week high 1,750
Beta 0.32
50-Day moving average 1,220.8
200-Day moving average 1,312.01

Financials

Fiscal year

Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin 0.42%
Operating margin 0.37%

Operational effectiveness

Return on assets 0.16%
Return on equity 0.2%

Income Statement

Revenue (ttm) 1.29B
Revenue per share (ttm) 1.9
Quarterly revenue growth (yoy) 0.98%
Gross profit (ttm) 926.03M
EBITDA 704.7M
Net income to common (ttm) 574.68M
Diluted EPS (ttm) 0.79
Quarterly earnings growth (yoy) 0.62%

Balance Sheet

Total cash (mrq) 227.67M
Total cash per share (mrq) 1.3
Total debt (mrq) 2.62M
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 5.27%
Book value per share (mrq) 4.27

Cash Flow

Cash flow statement 619.97M
Levered free cash flow (LFCF) 476.91M